Unverified50% confidenceFactExact time
HPK1 (hematopoietic progenitor kinase 1) is a negative regulator of the T-cell receptor signaling pathway, and inhibiting HPK1 can enhance anti-tumor immune responses, making it a hot target in immuno-oncology.
1
Sources
50%
Confidence
Long-term
Relevance
10/19/2026
First Seen
Sources
Related Entities
Related Claims
UnverifiedIn a prospective HPK1 study, DrugHarness achieved more favorable median docking scores than Biomni among system-specific candidate molecules.56% similarUnverifiedThe HPA axis has a built-in negative feedback mechanism whereby elevated cortisol in turn suppresses the secretion of CRH and ACTH, causing hormone levels to automatically decline.56% similarUnverifiedPCSK9、LDLR和APOB三个基因均与脂质代谢及心血管疾病密切关联52% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1065887API
curl https://kongchang.com/api/v1/knowledge/claims/1065887MCP
get_claim(id=1065887)